Todd Zion

Co-founder, President & CEO at Akston Biosciences Corporation - Beverly, MA, US

Todd Zion's Contact Details
HQ
N/A
Location
Beverly,Massachusetts,United States
Company
Akston Biosciences Corporation
Todd Zion's Company Details
Akston Biosciences Corporation logo, Akston Biosciences Corporation contact details

Akston Biosciences Corporation

Beverly, MA, US • 20 - 49 Employees
BioTech/Drugs

Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics, including vaccines, ultra-long-acting insulins, and autoimmune disease therapies. Founded by the team that developed the world's first clinical glucose-responsive insulin at SmartCells, Inc., Akston's COVID-19 vaccine candidate is in Phase II trials in the Netherlands. It has partnered with Dechra Pharmaceuticals PLC to commercialize once-a-week canine and feline insulin therapies. The company employs 35 people, has over 3,500 ft2 of research laboratory space and a 12,400 ft2 GMP clean room biologics manufacturing facility.

Biotechnology Insulin Engineering Biologics Manufacturing Diabetes Drug Development Immunotherapy
Details about Akston Biosciences Corporation
Frequently Asked Questions about Todd Zion
Todd Zion currently works for Akston Biosciences Corporation.
Todd Zion's role at Akston Biosciences Corporation is Co-founder, President & CEO.
Todd Zion's email address is ***@akstonbio.com. To view Todd Zion's full email address, please signup to ConnectPlex.
Todd Zion works in the Research industry.
Todd Zion's colleagues at Akston Biosciences Corporation are Andrea Delpero, Melanie Scully, Jeffrey Haworth, Rassol Laleau, Sanchi Jain, Nishit Shah, Michael Gennaco and others.
Todd Zion's phone number is N/A
See more information about Todd Zion